Webcast: AI-Driven MedTech Trials: Faster Evidence, Smarter Decisions

The MedTech regulatory landscape is accelerating—raising the bar on evidence, speed, and real-world relevance. Traditional trial models can’t keep up. Join this session to see how AI, synthetic evidence, and in silico trials are redefining clinical development from feasibility to post-market.

You’ll learn how AI, synthetic evidence, and in silico trials are redefining the clinical development process. Learn how leading innovators are:

• Designing smarter studies and simulating outcomes before first patient in
• Using synthetic patient populations to optimize protocol design, boost enrollment accuracy, and test hard-to-enroll groups
• Generating regulatory-grade evidence faster—from feasibility to post-market

Hear real-world case studies, see how evolving frameworks are shaping adoption, and walk away with a clear view of how to scale smarter, faster MedTech trials.